Core Viewpoint - The company ST Ningke announced a joint venture with Hangzhou Hecarbon to establish Ningxia Zhongke Hecarbon Chuangwu Biotechnology Co., Ltd. with a registered capital of 20 million yuan [1] Group 1: Joint Venture Details - The company will contribute 10.2 million yuan in cash, holding a 51% stake in the joint venture [1] - The board of directors has approved the proposal, which does not require shareholder approval and does not constitute a related party transaction or a major asset restructuring [1] Group 2: Strategic Intent - The investment aims to introduce algal oil fatty acid products, enhance capacity utilization, and reduce the risk associated with a single main product [1] Group 3: Future Considerations - There is uncertainty regarding the approval of the subsidiary's registration, and future operations may face risks related to the macroeconomic environment and market development [1]